Signs Joint Rd Partnership Agreement With Insilico Medicine
22/06/2026 05:58
BRIEF-Sk Biopharmaceuticals Co - Signs Joint Rd Partnership Agreement With Insilico Medicine SK Biopharmaceuticals Co Ltd 326030.KS:
SK BIOPHARMACEUTICALS CO - SIGNS JOINT RD PARTNERSHIP AGREEMENT WITH INSILICO MEDICINE
SK BIOPHARMACEUTICALS CO - JOINT RESEARCH TO DISCOVER CNS NEUROIMMUNE DRUG CANDIDATES USING INSILICO AI PLATFORM
SK BIOPHARMACEUTICALS CO - CONTRACT SIZE UP TO 3.95 TLN WON (USD 2.57 BILLION) PAYABLE TO INSILICO MEDICINE
Source text: [ID:]
Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals Co
See all newsInsilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
Signs Joint Rd Partnership Agreement With Insilico Medicine
Brief: Insilico Medicine Cayman TopCo Says Co & SK Biopharmaceuticals Enter AI-Powered RD Collab Worth Up To $2.5 Bln
Brief: SK Life Science Announces FDA Acceptance For Review Of New Drug Application For Cenobamate Oral Suspension
Announces Pharmaceutical Supply Contract